COVID-19-induced Scalp Alopecia Treated Effectively with Stem Cell Serum

Up to 36.7% of symptomatic COVID-19 patients will have telogen effluvium (TE), which refers to diffuse scalp alopecia. With the continuing global pandemic, a review of literature reports unpredictable and incomplete recovery with conventional treatment like minoxidil. The pathogenesis of COVID-19-in...

Descripción completa

Detalles Bibliográficos
Autores principales: Ong, Samuel Wei Qiang, Ong, Kathleen Hui Xin, Lee, Shu Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Reconstructive
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208741/
https://www.ncbi.nlm.nih.gov/pubmed/35733924
http://dx.doi.org/10.1097/GOX.0000000000004423

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208741/
https://www.ncbi.nlm.nih.gov/pubmed/35733924
http://dx.doi.org/10.1097/GOX.0000000000004423

Ejemplares similares